Protagenic Therapeutics (PTIX): O‘sish sur’atiga tuzatilgan narx-foyda
Protagenic Therapeutics (PTIX) xavotirlanishni davolash uchun neuropeptid vositalarini ishlab chiqmoqda, ammo joriy sinov bosqichi tufayli hali barqaror daromadga erisha olmagan. PEG koeffitsiyenti kompaniyaning matematik bahosini taqdim etadi, bunda 0.00 ushbu parametrning joriy darajasini belgilaydi. Startap aksiyalar opsionlari va tadqiqot avtonomiyasi orqali noyob bioximiklarni jalb qilmoqda. Shu bilan birga, PT00114 molekulasi uchun ko'ngillilar bazasi FDA qat'iy nazorati ostida kengaymoqda.
Protagenic Therapeutics (PTIX) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati protagenic.com|PTIX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Protagenic|PTIX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Protagenic Therapeutics|Tezkor likvidlik ko‘rsatkichi protagenic.com
- foyda va bozor koeffitsiyentlari statistikasi:
PTIX - Sof daromad|Kutilayotgan sof daromad Protagenic Therapeutics|PTIX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati protagenic.com|PTIX - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Protagenic|PTIX - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Protagenic Therapeutics|PTIX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi protagenic.com|PTIX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Protagenic Therapeutics
Kompaniyaning fundamental tahlili:Protagenic Therapeutics Inc. (PTIX)
Depressiya terapiyasi uchun peptidlar ishlab chiqish Protagenic Therapeutics (PTIX) kompaniyasini strategik hamkorlarni qidirishga yo'naltirmoqda, bu esa foyda kengayish sur'atlarini baholashni o'ta muhim qiladi. Ushbu ko'rsatkich P/E bozor multiplikatorini foyda o'sish sur'ati bilan solishtiradi va qiymat birdan past bo'lganda aktivning qadrini past baholanganini aniqlaydi, bu esa kompaniyaning fundamental barqarorligi kontekstida foyda o'sishiga nisbatan P/E dinamikasi orqali yaqqol aks etadi.
Raqobatdosh kompaniyalar
BIIB (Biogen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|Regencell Corp (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM: Narx-foyda va o‘sish multiplikatori|acadia-pharm.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|XENE: PEG multiplikatori|Viking Therapeutics Inc (VKTX) - PEG multiplikatori|SUPN (Supernus Pharma) - PEG multiplikatori|CPRX - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Trevi Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Praxis Corp PRAX|AVXL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori ceribell.com|Narx-foyda va o‘sish multiplikatori PRTA|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ANNX (Annexon Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati OMER|PEG multiplikatori NGNE (Neurogene Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Neumora|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ACOG (Alpha Cognition Inc) - PEG multiplikatori|PEG multiplikatori cogrx.com|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|SAVA: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - O‘sish sur’atiga tuzatilgan narx-foyda|VTGN: Narx-foyda va o‘sish multiplikatori|OVID - PEG multiplikatori|ABOS (Acumen Pharmaceuticals, Inc.) - Narx-foyda va o‘sish multiplikatori|CRVO: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|Clene Nanomedicine (CLNN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori PEPG|Narx-foyda va o‘sish multiplikatori jupiterneurosciences.com JUNS|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Annovis Bio Inc (ANVS)|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati AIFF|KLTO (anewmeds.com) - Narx-foyda va o‘sish multiplikatori|NRSN: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - PEG multiplikatori|MetaVia, Inc. (MTVA) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NRXS (NeurAxis, Inc)|heliusmedical.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Minerva Neurosciences, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Narx-foyda va o‘sish multiplikatori|Alzamend Neuro (ALZN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|KTTA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA (Cara Therapeutics Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ELYM (Eliem Therapeutics)|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Longboard Pharmaceuticals Inc (LBPH)|Narx-foyda va o‘sish multiplikatori MRNS|NKGN (NKGen Biotech Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NRBO|PEG multiplikatori sagerx.com (SAGE)|PEG multiplikatori SNPX (Synaptogenix)|Narxning sof foyda o‘sishiga nisbati Trevena Inc.|Vigil Neuro - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
